Nektar Therapeutics | NKTR - Ebitda


Nektar Therapeutics reported $-38.9M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Agios Pharmaceuticals USD -109.2M 540K Jun/2026
ALKERMES USD 120.06M 19.15M Sep/2026
Alterity Therapeutics Limited AUD -7.72M 2.99M Jun/2023
Amgen USD 5.8B 1.25B Sep/2026
Baxter International USD 474M 165M Jun/2026
BioCryst Pharmaceuticals USD 51.7M 30.14M Sep/2025
Biogen USD 450.8M 198.9M Jun/2026
Bristol-Myers Squibb USD 3.48B 1.6B Sep/2026
Cara Therapeutics USD -2.39M 3.16M Mar/2025
Cipla INR 13.88B 154.2M Sep/2026
Dr.Reddys Laboratories INR 8.6B 2.14B Jun/2026
Eisai JPY 34.15B 34.48B Jun/2026
Eli Lilly USD 9.46B 3.54B Sep/2026
Exelixis USD 275.36M 19.96M Sep/2026
Gilead Sciences USD -9.31B 12.82B Jun/2026
GlaxoSmithKline GBP 3.51B 734M Jun/2026
Grifols EUR 482.04M 7.04M Sep/2025
Halozyme Therapeutics USD 336.16M 7.34M Sep/2026
Incyte USD 778.57M 410.6M Jun/2026
Ionis Pharmaceuticals USD -64.53M 135.49M Mar/2026
Ironwood Pharmaceuticals USD 81.81M 31.71M Sep/2025
Karyopharm Therapeutics USD -26.2M 1.83M Sep/2024
MacroGenics USD -64.54M 34.34M Jun/2026
Merck USD 1.42B 2.97B Jun/2026
Nektar Therapeutics USD -38.9M 7.09M Mar/2026
Neurocrine Biosciences USD 375.3M 185.4M Sep/2026
Novartis USD 8.62B 2.14B Sep/2026
Pfizer USD 6.36B 350M Sep/2026
Roche Holding CHF 13.43B 744M Jun/2026
Sarepta Therapeutics USD -3.14M 33.31M Sep/2026
Takeda JPY 369.75B 5.29B Sep/2026
Teva Pharmaceutical Industries USD 1.5B 1.02B Sep/2026
Xencor USD 25.1M 59.73M Sep/2026